Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Arq Bras Cardiol ; 64(5): 463-4, 1995 May.
Artigo em Português | MEDLINE | ID: mdl-8526778

RESUMO

Hemoglobinopathies are associated with thrombotic complications, when exposed to cardiopulmonary bypass. A 54-year old, black woman with hemoglobinopathy SC and severe mitral stenosis was submitted to eritrocytopheresis 48 hours before mitral commissurotomy surgery. The therapeutic determined appearance of the percentual hemoglobin A of 68% with reduction the hemoglobin S of 48% to 15% and the hemoglobin C of 51% to 17%. No complications occurred during postoperative period. To best of our knowledge, that is the first report about application the eritrocytopheresis in the pre operative extra corporeal circulation care in surgical treatment of patients with chronic rheumatic heart disease and hemoglobinopathy SC.


Assuntos
Transfusão de Eritrócitos , Doença da Hemoglobina SC/complicações , Estenose da Valva Mitral/cirurgia , Feminino , Humanos , Pessoa de Meia-Idade , Estenose da Valva Mitral/complicações , Cuidados Pré-Operatórios
2.
Arq Bras Cardiol ; 63(5): 389-91, 1994 Nov.
Artigo em Português | MEDLINE | ID: mdl-7611917

RESUMO

A 52 year-old man, with rheumatic cardiopathy and hemophilia was admitted to the hospital for aortic valve replacement and mitral valve commisurotomy. He had a history of allergic reaction to cryoprecipitate, and to undergo to the cardiac surgery, the ideal level of factor VIII was estimated to be 100%. To reach this level he first received 2,500UI of the factor VIII:C increasing the factor VIII:C level from 20 to 58%. During the surgery he received an additional dose of 1,500UI of factor VIII plus 3,500,000UI of aprotinin (Trasylol), which was started at the beginning of the anaesthesia and maintained during the surgical procedure, increasing the factor VIII level to 220%. The patient was discharged 11 days after the surgery without any hemorrhagic complication.


Assuntos
Estenose da Valva Aórtica/cirurgia , Bioprótese , Próteses Valvulares Cardíacas , Hemofilia A/complicações , Estenose da Valva Mitral/cirurgia , Cardiopatia Reumática/cirurgia , Estenose da Valva Aórtica/complicações , Perda Sanguínea Cirúrgica/prevenção & controle , Fator VIII/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Estenose da Valva Mitral/complicações , Cardiopatia Reumática/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA